arginyl-glycyl-aspartic acid has been researched along with Leukemia, Myeloid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blumenfeld, J; Gu, ZJ; Li, S; Miao, J; Xia, W; Yang, J; Yu, X; Zhang, B | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Leukemia, Myeloid
| Article | Year |
|---|---|
Antitumor effect and underlying mechanism of RGD-modified adenovirus mediated IL-24 expression on myeloid leukemia cells.
Topics: Adenoviridae; Animals; Apoptosis; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Genetic Therapy; Humans; Interleukins; Leukemia, Myeloid; Mice, Nude; Oligopeptides; RNA, Messenger; Tumor Burden | 2015 |